Key malaria facts
- Annual cases of malaria
- Globally: 247 million
Africa: 212 million
Asia: 21 million
Middle East: 8.1 million
Americas: 2.7 million - Annual deaths from malaria
- Globally: 881,000
Africa: 801,000
Middle East: 38,000
Asia: 36,000
Americas: 3,000 - Figures on malaria deaths
- 91% of deaths were in Africa
85% of deaths were in children under 5 years of age
4% of deaths were in South-East Asia region (especially India)
4% of deaths were in Eastern Mediterranean region (especially Sudan) - Population at risk
- 3.3 billion (half of the world population)
- Number of countries affected
- 109
(35 countries - 30 in Sub-Saharan Africa and 5 in Asia - account for 98 percent of global malaria deaths) - Top five countries for malaria numbers
- Nigeria: 57,506,000
Democratic Republic of the Congo: 23,620,000
Ethiopia: 12,405,000
United Republic of Tanzania: 11,540,000
Kenya: 11,342,000 - Top five countries for malaria deaths
- Nigeria: 225,424
Democratic Republic of the Congo: 96,113
Uganda: 43,490
Ethiopia: 40,963
United Republic of Tanzania: 38,730 - Required health expenditure (Abuja declaration)
- 15% of national budget
- Child mortality from malaria
- 85% of deaths in children under 5 years old
- Economic cost
- Direct: USD 12 billion per year in direct losses,
lost 1.3% of GDP growth per year for Africa.
For Nigeria alone the direct loss to the economy is estimated at GBP530 million - Burden
- 35.4 million Disability Adjusted Life Years (sub-Saharan Africa)
- Cost per DALY averted
- USD 2-24 (sub-Saharan Africa)
- Cost of malaria
- Around 40% of public health spending in sub-Saharan Africa
20-50% of inpatient admissions
Up to 50% of outpatient visits - Average household spending
- Over 10% of yearly spending in Africa
Direct costs $0.41 in Malawi, $7.38 in Ghana - Financial need to tackle Malaria
- 2009: USD 5.335 billion
2010: USD 6.180 billion
2011-2020: USD 5.126 billion (average) - Annual funding
- 2007: USD 1.107 billion
Funding gap: USD 4,266 billion - Required investment in research (10 years)
- USD 8.9 billion
- Current level of coverage
- Treatment: more than 100 million
Nets: 66.2 million
Diagnostics: 16 million rapid diagnostics tests delivered in 2006 among which 11 million in Africa - Required coverage by 2010
- Protective nets: 730 million long-lasting insecticidal nets (LLINs). (350 million in Africa)
Indoor spraying with insecticide: 172 million households need annual spraying.
Preventive treatment for pregnant women: 25 million pregnant women annually.
Diagnostic tests: approximately 1.5 billion annually.
Drugs: 228 million doses of ACTs are needed to treat P. falciparum annually; additional 19 million doses of chloroquine and primaquine are needed annually for P.vivax. - Impact of full coverage
- Up to an estimated 4.2 million lives could be saved by 2015 in the 20 highest burden African countries alone.
- Malaria and humanitarian crises
- Up to 30% of malaria deaths in Africa occur in the wake of war, local violence or natural disasters.
- MDGs that could be impacted by addressing malaria problem
- MDG 1 – Eradicating extreme poverty and hunger
MDG 2 – Achieve universal primary education
MDG 4 – Reduce child mortality
MDG 5 – Improve maternal health
MDG 6 – Combat HIV/AIDS, malaria and other diseases
MDG 8 – global partnerships for development and access to affordable drugs - Costs of interventions
- Long-lasting insecticidal net: $10 (includes the net, distribution, teaching usage and monitoring usage)
Course of ACTs for adult: $6 - Impact in tackling malaria
- Eritrea, Rwanda, and Sao Tome and Principe reported declines in the number of cases and deaths of 50% or more between 2000 and 2006–2007 following high coverage of control activities. In addition, 22 countries outside of Africa reported declines of 50% or more in malaria cases and deaths between 2000 and 2006.
Source: Global Malaria Action Plan (2008)